Buzdar AU - Search Results

1

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.

Bastarrachea J, Hortobagyi GN, Smith TL, Kau SW, Buzdar AU. Bastarrachea J, et al. Among authors: buzdar au. Ann Intern Med. 1994 Jan 1;120(1):18-25. doi: 10.7326/0003-4819-120-1-199401010-00004. Ann Intern Med. 1994. PMID: 8250452

2

Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease.

Rivera E, Holmes FA, Buzdar AU, Asmar L, Kau SW, Fraschini G, Walters R, Theriault RL, Hortobagyi GN. Rivera E, et al. Among authors: buzdar au. Breast J. 2002 Jan-Feb;8(1):2-9. doi: 10.1046/j.1524-4741.2002.08002.x. Breast J. 2002. PMID: 11856154 Clinical Trial.

3

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Buzdar AU, Singletary SE, Valero V, Booser DJ, Ibrahim NK, Rahman Z, Theriault RL, Walters R, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD, Strom E, Thomas E, Hunt K, Ames F, Berry D, Hortobagyi GN. Buzdar AU, et al. Clin Cancer Res. 2002 May;8(5):1073-9. Clin Cancer Res. 2002. PMID: 12006521 Clinical Trial.

4

Breast cancer in men.

Giordano SH, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Ann Intern Med. 2002 Oct 15;137(8):678-87. doi: 10.7326/0003-4819-137-8-200210150-00013. Ann Intern Med. 2002. PMID: 12379069 Review.

5

Estrogen receptors and distinct patterns of breast cancer relapse.

Hess KR, Pusztai L, Buzdar AU, Hortobagyi GN. Hess KR, et al. Among authors: buzdar au. Breast Cancer Res Treat. 2003 Mar;78(1):105-18. doi: 10.1023/a:1022166517963. Breast Cancer Res Treat. 2003. PMID: 12611463

6

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.

Zhang F, Yang Y, Smith T, Kau SW, McConathy JM, Esteva FJ, Kuerer HM, Symmans WF, Buzdar AU, Hortobagyi GN, Pusztai L. Zhang F, et al. Among authors: buzdar au. Cancer. 2003 Apr 1;97(7):1758-65. doi: 10.1002/cncr.11245. Cancer. 2003. PMID: 12655533 Free article.

7

Is breast cancer survival improving?

Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Cancer. 2004 Jan 1;100(1):44-52. doi: 10.1002/cncr.11859. Cancer. 2004. PMID: 14692023 Free article.

8

Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.

Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, Hortobagyi GN. Blakely LJ, et al. Among authors: buzdar au. Cancer. 2004 Feb 1;100(3):465-9. doi: 10.1002/cncr.11929. Cancer. 2004. PMID: 14745861 Free article.

9

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.

Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, Nahta R, Buchholz TA, Buzdar AU, Hortobagyi GN, Bacus SS. Esteva FJ, et al. Among authors: buzdar au. Cancer. 2004 Feb 1;100(3):499-506. doi: 10.1002/cncr.11940. Cancer. 2004. PMID: 14745865 Free article. Clinical Trial.

10

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.

Cristofanilli M, Gonzalez-Angulo AM, Buzdar AU, Kau SW, Frye DK, Hortobagyi GN. Cristofanilli M, et al. Among authors: buzdar au. Clin Breast Cancer. 2004 Feb;4(6):415-9. doi: 10.3816/cbc.2004.n.004. Clin Breast Cancer. 2004. PMID: 15023242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters